Work

Association of tumor-informed ctDNA-based molecular residual disease (MRD) with clinical outcomes for upper tract urothelial cancer (UTUC).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.4565

Authors: Adanma Ayanambakkam, George Laliotis, Kevin R. Reyes, Beaux Mitchell, Cherry Au, Michael Glover, Margaret F. Meagher, Punashi Dutta, Shruti Sharma, Meenakshi Malhotra, Adam ElNaggar, Minetta C. Liu, Mukti Patel, Sumit Anil Shah, Alan Tan, Vadim S. Koshkin, Tyler F. Stewart

Institutions: OU Health Stephenson Cancer Center, University of Oklahoma Health Sciences Center, University of California, San Francisco, Rush University Medical Center, Stanford Medicine, UC San Diego Health System, Vanderbilt University Medical Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410823134

Cites:

Cited by: 2

Related to: 10